| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
269,764,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
11,686,762 |
Avg
Vol: |
5,279,592 |
| 52
Week Range: |
$76.25 - $76.25 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
NASDAQ-100 |
| |
S&P 500 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Smith Alan E |
Sr VP,Chief Scientific Officer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$2,783,954 |
D/D |
(37,621) |
0 |
|
- |
|
| Smith Alan E |
Sr VP,Chief Scientific Officer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$578,310 |
D/D |
(7,815) |
37,621 |
|
- |
|
| Smith Alan E |
Sr VP,Chief Scientific Officer |
• – – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,815 |
45,436 |
|
- |
|
| Meeker David P |
ExecVP,Chief Operating Officer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$98,124 |
I/I |
(1,326) |
0 |
|
- |
|
| Meeker David P |
ExecVP,Chief Operating Officer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$2,164,500 |
D/D |
(29,250) |
0 |
|
- |
|
| Meeker David P |
ExecVP,Chief Operating Officer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$780,774 |
D/D |
(10,551) |
29,250 |
|
- |
|
| Meeker David P |
ExecVP,Chief Operating Officer |
• – – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,250 |
39,801 |
|
- |
|
| Wirth Peter |
Exec VP,Legal & Corporate Dev. |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$10,952 |
I/I |
(148) |
0 |
|
- |
|
| Wirth Peter |
Exec VP,Legal & Corporate Dev. |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$2,164,500 |
D/D |
(29,250) |
0 |
|
- |
|
| Wirth Peter |
Exec VP,Legal & Corporate Dev. |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$1,158,840 |
D/D |
(15,660) |
29,250 |
|
- |
|
| Wirth Peter |
Exec VP,Legal & Corporate Dev. |
• – – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,250 |
44,910 |
|
- |
|
| Moscicki Richard A |
Sr VP,Chief Medical Officer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$16,132 |
I/I |
(218) |
0 |
|
- |
|
| Moscicki Richard A |
Sr VP,Chief Medical Officer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$1,541,420 |
D/D |
(20,830) |
0 |
|
- |
|
| Moscicki Richard A |
Sr VP,Chief Medical Officer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$1,166,388 |
D/D |
(15,762) |
20,830 |
|
- |
|
| Moscicki Richard A |
Sr VP,Chief Medical Officer |
• – – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,762 |
36,592 |
|
- |
|
| Desrosier Thomas |
Sr VP, General Counsel |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$481,370 |
I/I |
(6,505) |
0 |
|
- |
|
| Desrosier Thomas |
Sr VP, General Counsel |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$841,750 |
D/D |
(11,375) |
0 |
|
- |
|
| Desrosier Thomas |
Sr VP, General Counsel |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$424,612 |
D/D |
(5,738) |
11,375 |
|
- |
|
| Desrosier Thomas |
Sr VP, General Counsel |
• – – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,375 |
17,113 |
|
- |
|
| Smith Sandford D |
Exe VP,President Intl Group |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$1,529,654 |
D/D |
(20,671) |
0 |
|
- |
|
| Smith Sandford D |
Exe VP,President Intl Group |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$1,073,000 |
D/D |
(14,500) |
20,671 |
|
- |
|
| Smith Sandford D |
Exe VP,President Intl Group |
• – – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,500 |
35,171 |
|
- |
|
| Termeer Henri A |
Chmn, President and CEO |
• • – |
2011-04-04 |
4 |
D |
$74.00 |
$1,665,740 |
I/I |
(22,510) |
0 |
|
- |
|
| Termeer Henri A |
Chmn, President and CEO |
• • – |
2011-04-04 |
4 |
D |
$74.00 |
$34,828,470 |
D/D |
(470,655) |
0 |
|
- |
|
| Termeer Henri A |
Chmn, President and CEO |
• • – |
2011-04-04 |
4 |
D |
$74.00 |
$4,792,832 |
D/D |
(64,768) |
470,655 |
|
- |
|
604 Records found
|
|
Page 3 of 25 |
|
|
